Hi ya Ruperton, anyone, not to my knowledge has Goldman Sachs acknowledge the latest CXO sales offtake (Sichuan Yahau) at FastMarkets spodumene SC6 China spot price, no floor, no ceiling, a really great call from management to off load approx 10% of uncontracted spod before deliveries of contracted agreements commence soon.
Goldman Sachs changing the narrative, hopefully their 90c sell will change soon.
Macquarie Bank buy $110.00 outperform
Sentiment in CXO revenue combined with deliverance on growth strategy, could be the short killer near term, as the lows in CXO SP , hopefully with spodumene price at the floor.
We wait to see action in Q2 for Core Lithium.
CXO - Chart Thread, page-5929
-
- There are more pages in this discussion • 2,950 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CXO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $214.3M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 11.0¢ | 10.0¢ | $1.502M | 14.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 78 | 5970714 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 250000 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| CXO (ASX) Chart |